Merus (MRUS) News Today $43.36 -0.83 (-1.88%) Closing price 05/5/2025 04:00 PM EasternExtended Trading$43.37 +0.01 (+0.02%) As of 04:13 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Merus (NASDAQ:MRUS) Short Interest UpdateMerus (NASDAQ:MRUS - Get Free Report) saw a large drop in short interest in April. As of April 15th, there was short interest totalling 6,270,000 shares, a drop of 15.5% from the March 31st total of 7,420,000 shares. Based on an average daily trading volume, of 707,000 shares, the days-to-cover ratio is currently 8.9 days. Approximately 9.6% of the shares of the company are short sold.May 5 at 7:58 AM | marketbeat.comMerus (NASDAQ:MRUS) Receives $85.31 Consensus PT from BrokeragesMay 5 at 1:49 AM | americanbankingnews.comAllostery Investments LP Makes New Investment in Merus (NASDAQ:MRUS)Allostery Investments LP bought a new position in Merus (NASDAQ:MRUS - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 21,735 shares of the biotechnology company's stock, valued at approximately $914,000. MerusMay 4 at 7:45 AM | marketbeat.comMerus (NASDAQ:MRUS) is Ally Bridge Group NY LLC's 7th Largest PositionAlly Bridge Group NY LLC trimmed its holdings in Merus (NASDAQ:MRUS - Free Report) by 43.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 116,796 shares of the biotechnology company's stock after selling 91,448 shares during the quaMay 4 at 7:45 AM | marketbeat.com1,900,000 Shares in Merus (NASDAQ:MRUS) Acquired by Boxer Capital Management LLCBoxer Capital Management LLC acquired a new stake in Merus (NASDAQ:MRUS - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 1,900,000 shares of the biotechnology company's stock, valued at approximately $79,895,00May 4 at 6:25 AM | marketbeat.comMerus (NASDAQ:MRUS) Receives Consensus Recommendation of "Buy" from AnalystsMerus (NASDAQ:MRUS - Get Free Report) has received a consensus recommendation of "Buy" from the sixteen brokerages that are presently covering the firm, MarketBeat reports. Fourteen analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the coMay 4 at 2:58 AM | marketbeat.comNovo Holdings A S Buys 50,000 Shares of Merus (NASDAQ:MRUS)Novo Holdings A S boosted its stake in Merus (NASDAQ:MRUS - Free Report) by 7.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 750,000 shares of the biotechnology company's stock after purchasing an additionMay 3 at 8:09 AM | marketbeat.com255,000 Shares in Merus (NASDAQ:MRUS) Acquired by Caligan Partners LPCaligan Partners LP bought a new stake in shares of Merus (NASDAQ:MRUS - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 255,000 shares of the biotechnology company's stock, valued at approximatMay 3 at 7:45 AM | marketbeat.comLeerink Partnrs Has Pessimistic Outlook of Merus Q1 EarningsMerus (NASDAQ:MRUS - Free Report) - Equities researchers at Leerink Partnrs reduced their Q1 2025 earnings per share (EPS) estimates for Merus in a note issued to investors on Monday, April 28th. Leerink Partnrs analyst A. Berens now forecasts that the biotechnology company will post earnings ofMay 3 at 6:49 AM | marketbeat.comMerus (NASDAQ:MRUS) Shares Sold by Aquatic Capital Management LLCAquatic Capital Management LLC lowered its stake in Merus (NASDAQ:MRUS - Free Report) by 24.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 18,247 shares of the biotechnology company's stock after selliMay 3 at 5:10 AM | marketbeat.comLeerink Partnrs Issues Negative Outlook for Merus EarningsMay 3 at 1:12 AM | americanbankingnews.comFY2027 Earnings Estimate for Merus Issued By Leerink PartnrsMerus (NASDAQ:MRUS - Free Report) - Analysts at Leerink Partnrs decreased their FY2027 earnings per share (EPS) estimates for Merus in a research report issued on Monday, April 28th. Leerink Partnrs analyst A. Berens now anticipates that the biotechnology company will post earnings per share of $May 2, 2025 | marketbeat.comSusquehanna Fundamental Investments LLC Buys Shares of 53,938 Merus (NASDAQ:MRUS)Susquehanna Fundamental Investments LLC bought a new stake in Merus (NASDAQ:MRUS - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 53,938 shares of the biotechnology company's stock, valued at approximately $2,268May 2, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Lowers Position in Merus (NASDAQ:MRUS)Price T Rowe Associates Inc. MD cut its position in shares of Merus (NASDAQ:MRUS - Free Report) by 12.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,116,820 shares of the biotechnology company's sMay 2, 2025 | marketbeat.comMerus' (MRUS) "Outperform" Rating Reaffirmed at William BlairWilliam Blair reiterated an "outperform" rating on shares of Merus in a research note on Monday.April 30, 2025 | marketbeat.comBoothbay Fund Management LLC Acquires New Shares in Merus (NASDAQ:MRUS)Boothbay Fund Management LLC acquired a new stake in shares of Merus (NASDAQ:MRUS - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund acquired 80,000 shares of the biotechnology company's stock, valued at approximately $3,364,000. Boothbay Fund ManagApril 30, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Shares Acquired by Adage Capital Partners GP L.L.C.Adage Capital Partners GP L.L.C. lifted its position in shares of Merus (NASDAQ:MRUS - Free Report) by 35.1% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 250,000 shares of the biotechnology company's stock after buying an additional 65,000 shares duriApril 30, 2025 | marketbeat.comArtia Global Partners LP Has $19.50 Million Stock Position in Merus (NASDAQ:MRUS)Artia Global Partners LP grew its stake in Merus (NASDAQ:MRUS - Free Report) by 478.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 463,840 shares of the biotechnology company's stock after acApril 29, 2025 | marketbeat.comMerus (NASDAQ:MRUS) is Lynx1 Capital Management LP's Largest PositionLynx1 Capital Management LP cut its position in Merus (NASDAQ:MRUS - Free Report) by 11.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,580,841 shares of the biotechnology company's stock afteApril 29, 2025 | marketbeat.comTri Locum Partners LP Boosts Holdings in Merus (NASDAQ:MRUS)Tri Locum Partners LP increased its stake in shares of Merus (NASDAQ:MRUS - Free Report) by 80.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 347,303 shares of the biotechnology company's stock afteApril 29, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Stock Position Decreased by T. Rowe Price Investment Management Inc.T. Rowe Price Investment Management Inc. decreased its holdings in shares of Merus (NASDAQ:MRUS - Free Report) by 2.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 808,576 shares of the biotechnology comApril 29, 2025 | marketbeat.comSilverarc Capital Management LLC Acquires 45,406 Shares of Merus (NASDAQ:MRUS)Silverarc Capital Management LLC increased its position in shares of Merus (NASDAQ:MRUS - Free Report) by 7.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 680,845 shares of the biotechnology comApril 24, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Trading 4.8% Higher - Here's WhyMerus (NASDAQ:MRUS) Stock Price Up 4.8% - Time to Buy?April 23, 2025 | marketbeat.comMerus N.V. Announces Interim Clinical Data for Petosemtamab with Pembrolizumab in PD-L1+ r/m HNSCC to be Presented at 2025 ASCO® Annual MeetingApril 23, 2025 | quiverquant.comMerus Announces Abstract Accepted for Presentation at the 2025 ASCO® Annual MeetingApril 23, 2025 | globenewswire.comMerus (NASDAQ:MRUS) Shares Purchased by Avoro Capital Advisors LLCAvoro Capital Advisors LLC boosted its holdings in Merus (NASDAQ:MRUS - Free Report) by 56.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,125,000 shares of the biotechnology company's stock after buyingApril 23, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Shares Sold by Marshall Wace LLPMarshall Wace LLP lowered its position in shares of Merus (NASDAQ:MRUS - Free Report) by 23.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 862,089 shares of the biotechnology company's stock after selling 260,014 shares durApril 21, 2025 | marketbeat.comJump Financial LLC Sells 20,825 Shares of Merus (NASDAQ:MRUS)Jump Financial LLC decreased its holdings in Merus (NASDAQ:MRUS - Free Report) by 27.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 54,412 shares of the biotechnology company's stock aftApril 21, 2025 | marketbeat.comMerus’s Strategic Positioning and Growth Potential Justifies Buy RatingApril 20, 2025 | tipranks.comGilead Sciences Inc. Invests $19.03 Million in Merus (NASDAQ:MRUS)Gilead Sciences Inc. acquired a new stake in Merus (NASDAQ:MRUS - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 452,527 shares of the biotechnology company's stock, valued at approximately $19,029,000. Merus cApril 20, 2025 | marketbeat.comInvesco Ltd. Grows Stock Position in Merus (NASDAQ:MRUS)Invesco Ltd. lifted its holdings in Merus (NASDAQ:MRUS - Free Report) by 2.2% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 786,365 shares of the biotechnology company's stock after purchasing an additional 16,712 shares duApril 20, 2025 | marketbeat.comCapital Fund Management S.A. Invests $427,000 in Merus (NASDAQ:MRUS)Capital Fund Management S.A. bought a new stake in shares of Merus (NASDAQ:MRUS - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 10,158 shares of the biotechnology company's stock, valued atApril 19, 2025 | marketbeat.comIs Merus (NASDAQ:MRUS) the Best High Short Interest Stock to Buy Now?April 17, 2025 | msn.comMerus (NASDAQ:MRUS) Position Boosted by Affinity Asset Advisors LLCAffinity Asset Advisors LLC lifted its stake in Merus (NASDAQ:MRUS - Free Report) by 140.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 389,241 shares of the biotechnology company's stock after pApril 17, 2025 | marketbeat.comFmr LLC Has $290.13 Million Holdings in Merus (NASDAQ:MRUS)Fmr LLC lifted its holdings in shares of Merus (NASDAQ:MRUS - Free Report) by 0.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,899,521 shares of the biotechnology company's stock after buying an additApril 13, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Sets New 12-Month Low - Should You Sell?Merus (NASDAQ:MRUS) Reaches New 52-Week Low - Here's WhyApril 12, 2025 | marketbeat.comRaymond James Financial Inc. Invests $347,000 in Merus (NASDAQ:MRUS)Raymond James Financial Inc. purchased a new position in shares of Merus (NASDAQ:MRUS - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 8,231 shares of the biotechnology company's stock, valued at approxiApril 12, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Earns Buy Rating from Needham & Company LLCNeedham & Company LLC reiterated a "buy" rating and set a $83.00 target price on shares of Merus in a research report on Wednesday.April 11, 2025 | marketbeat.comCenterBook Partners LP Buys 124,174 Shares of Merus (NASDAQ:MRUS)CenterBook Partners LP raised its stake in Merus (NASDAQ:MRUS - Free Report) by 664.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 142,875 shares of the biotechnology company's stock after acquiriApril 11, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Shares Sold by ADAR1 Capital Management LLCADAR1 Capital Management LLC lowered its position in shares of Merus (NASDAQ:MRUS - Free Report) by 46.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 81,460 shares of the biotechnology company's stock after seApril 9, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Shares Sold by Federated Hermes Inc.Federated Hermes Inc. lessened its holdings in Merus (NASDAQ:MRUS - Free Report) by 20.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,593,375 shares of the biotechnology company's stock after selling 413,425 shareApril 9, 2025 | marketbeat.comSpringhill Fund Asset Management HK Co Ltd Invests $3.52 Million in Merus (NASDAQ:MRUS)Springhill Fund Asset Management HK Co Ltd bought a new position in Merus (NASDAQ:MRUS - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 83,800 shares of the biotechnology company's stock, valued at appApril 8, 2025 | marketbeat.comAlliancebernstein L.P. Increases Holdings in Merus (NASDAQ:MRUS)Alliancebernstein L.P. boosted its position in Merus (NASDAQ:MRUS - Free Report) by 9.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 796,957 shares of the biotechnology company'sApril 8, 2025 | marketbeat.comMerus: Riding The Bispecific Wave In OncologyApril 7, 2025 | seekingalpha.comTrexquant Investment LP Sells 9,711 Shares of Merus (NASDAQ:MRUS)Trexquant Investment LP trimmed its holdings in shares of Merus (NASDAQ:MRUS - Free Report) by 8.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 100,733 shares of the biotechnology company's stock after selling 9,711 shApril 7, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Reaches New 1-Year Low - Should You Sell?Merus (NASDAQ:MRUS) Sets New 12-Month Low - Here's WhyApril 6, 2025 | marketbeat.comKLP Kapitalforvaltning AS Purchases New Holdings in Merus (NASDAQ:MRUS)KLP Kapitalforvaltning AS acquired a new position in shares of Merus (NASDAQ:MRUS - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 10,300 shares of the biotechnology company's stock, valued at approximately $43April 6, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Shares Sold by Franklin Resources Inc.Franklin Resources Inc. reduced its position in Merus (NASDAQ:MRUS - Free Report) by 12.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,984,538 shares of the biotechnology company's stock after selling 271,966 shares durinApril 5, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Stock Position Lifted by Wellington Management Group LLPWellington Management Group LLP raised its stake in Merus (NASDAQ:MRUS - Free Report) by 21.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 3,497,653 shares of the biotechnology company's stock after buying an additional 610,139 sharesApril 5, 2025 | marketbeat.comMerus (NASDAQ:MRUS) Trading 7.5% Higher - Here's What HappenedMerus (NASDAQ:MRUS) Trading Up 7.5% - Should You Buy?April 4, 2025 | marketbeat.com Get Merus News Delivered to You Automatically Sign up to receive the latest news and ratings for MRUS and its competitors with MarketBeat's FREE daily newsletter. Email Address MRUS Media Mentions By Week MRUS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRUS News Sentiment▼0.890.72▲Average Medical News Sentiment MRUS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRUS Articles This Week▼286▲MRUS Articles Average Week Get Merus News Delivered to You Automatically Sign up to receive the latest news and ratings for MRUS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Dr. Reddy's Laboratories News Today Moderna News Today Ascendis Pharma A/S News Today Viatris News Today Qiagen News Today Roivant Sciences News Today Revolution Medicines News Today Lantheus News Today BridgeBio Pharma News Today TG Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRUS) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s Bitcoin Reserve is No Accident…Crypto policy is changing fast… Smart investors are positioning themselves to benefit. And it's all happeni...Crypto 101 Media | SponsoredElon Musk is all in on these robots …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merus Please log in to your account or sign up in order to add this asset to your watchlist. Share Merus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MRUS Stock Free MRUS Stock Alerts